We present two patients with > 80 years with type 1 diabetes (T1D), but with minor complications. Their history and risk factors are characterized as are factors conferring resilience against angiopathy. Amazingly, both had clearly detectable C-peptide. The underlying reasons for their benign phenotype could form the basis for novel treatment targets.
Sjöholm et al. (Sun,) studied this question.